Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16519 | 649 | 41.1 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
147 | 2 | SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//LIPOSOMES | 23275 |
16519 | 1 | NAB PACLITAXEL//ALBUMIN NANOPARTICLES//ABRAXANE | 649 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NAB PACLITAXEL | authKW | 1156843 | 11% | 35% | 71 |
2 | ALBUMIN NANOPARTICLES | authKW | 385991 | 3% | 43% | 19 |
3 | ABRAXANE | authKW | 381074 | 3% | 45% | 18 |
4 | HUMAN SERUM ALBUMIN NANOPARTICLES | authKW | 346445 | 1% | 82% | 9 |
5 | BSA NANOPARTICLES | authKW | 272203 | 1% | 64% | 9 |
6 | ALBUMIN BOUND PACLITAXEL | authKW | 204548 | 2% | 43% | 10 |
7 | COACERVATION METHOD | authKW | 192109 | 1% | 58% | 7 |
8 | ABI 007 | authKW | 169370 | 1% | 60% | 6 |
9 | HSA NANOPARTICLES | authKW | 150554 | 1% | 80% | 4 |
10 | GELATIN NANOPARTICLES | authKW | 150538 | 2% | 27% | 12 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2821 | 39% | 0% | 254 |
2 | Materials Science, Biomaterials | 2228 | 10% | 0% | 64 |
3 | Oncology | 762 | 19% | 0% | 125 |
4 | Nanoscience & Nanotechnology | 623 | 11% | 0% | 73 |
5 | Engineering, Biomedical | 348 | 6% | 0% | 41 |
6 | Chemistry, Multidisciplinary | 236 | 15% | 0% | 97 |
7 | Chemistry, Medicinal | 130 | 5% | 0% | 32 |
8 | Chemistry, Applied | 119 | 5% | 0% | 31 |
9 | Polymer Science | 100 | 6% | 0% | 38 |
10 | Biotechnology & Applied Microbiology | 50 | 5% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DEV THER EUT GRP | 94097 | 0% | 100% | 2 |
2 | ABRAXIS BIOSCI | 47049 | 0% | 100% | 1 |
3 | AIIM INNOVAT CAMPUS | 47049 | 0% | 100% | 1 |
4 | ATE BIOMED MAT TISSUE ENGN | 47049 | 0% | 100% | 1 |
5 | BARBARA K ROBINSON BREAST CANC PROGRAM | 47049 | 0% | 100% | 1 |
6 | BIOMED MATERIAL | 47049 | 0% | 100% | 1 |
7 | BRAMAN FAMILY BREAST CANC HEMATOL ONCOL | 47049 | 0% | 100% | 1 |
8 | CARDIOVASC INTERVENT RADIOL H3646 | 47049 | 0% | 100% | 1 |
9 | CAS BIOMED EFFECTS NANOPARTICLES NANOSA | 47049 | 0% | 100% | 1 |
10 | CHIM PROVENCECNRS UMR 6264 | 47049 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 6448 | 3% | 1% | 21 |
2 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 5974 | 7% | 0% | 45 |
3 | CLINICAL BREAST CANCER | 4951 | 1% | 1% | 9 |
4 | JOURNAL OF CONTROLLED RELEASE | 4247 | 4% | 0% | 26 |
5 | JOURNAL OF MICROENCAPSULATION | 3759 | 2% | 1% | 12 |
6 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 2467 | 2% | 0% | 14 |
7 | JOURNAL OF DRUG TARGETING | 2436 | 1% | 1% | 9 |
8 | ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY | 1560 | 1% | 1% | 4 |
9 | OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 1381 | 1% | 1% | 4 |
10 | EJC SUPPLEMENTS | 1305 | 0% | 1% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NAB PACLITAXEL | 1156843 | 11% | 35% | 71 | Search NAB+PACLITAXEL | Search NAB+PACLITAXEL |
2 | ALBUMIN NANOPARTICLES | 385991 | 3% | 43% | 19 | Search ALBUMIN+NANOPARTICLES | Search ALBUMIN+NANOPARTICLES |
3 | ABRAXANE | 381074 | 3% | 45% | 18 | Search ABRAXANE | Search ABRAXANE |
4 | HUMAN SERUM ALBUMIN NANOPARTICLES | 346445 | 1% | 82% | 9 | Search HUMAN+SERUM+ALBUMIN+NANOPARTICLES | Search HUMAN+SERUM+ALBUMIN+NANOPARTICLES |
5 | BSA NANOPARTICLES | 272203 | 1% | 64% | 9 | Search BSA+NANOPARTICLES | Search BSA+NANOPARTICLES |
6 | ALBUMIN BOUND PACLITAXEL | 204548 | 2% | 43% | 10 | Search ALBUMIN+BOUND+PACLITAXEL | Search ALBUMIN+BOUND+PACLITAXEL |
7 | COACERVATION METHOD | 192109 | 1% | 58% | 7 | Search COACERVATION+METHOD | Search COACERVATION+METHOD |
8 | ABI 007 | 169370 | 1% | 60% | 6 | Search ABI+007 | Search ABI+007 |
9 | HSA NANOPARTICLES | 150554 | 1% | 80% | 4 | Search HSA+NANOPARTICLES | Search HSA+NANOPARTICLES |
10 | GELATIN NANOPARTICLES | 150538 | 2% | 27% | 12 | Search GELATIN+NANOPARTICLES | Search GELATIN+NANOPARTICLES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ELZOGHBY, AO , SAMY, WM , ELGINDY, NA , (2012) ALBUMIN-BASED NANOPARTICLES AS POTENTIAL CONTROLLED RELEASE DRUG DELIVERY SYSTEMS.JOURNAL OF CONTROLLED RELEASE. VOL. 157. ISSUE 2. P. 168 -182 | 54 | 42% | 286 |
2 | KOUCHAKZADEH, H , SHOJAOSADATI, SA , (2016) THE PROMINENT ROLE OF PROTEIN-BASED DELIVERY SYSTEMS ON THE DEVELOPMENT OF CANCER TREATMENT.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 22. P. 3455 -3465 | 57 | 48% | 1 |
3 | ELZOGHBY, AO , (2013) GELATIN-BASED NANOPARTICLES AS DRUG AND GENE DELIVERY SYSTEMS: REVIEWING THREE DECADES OF RESEARCH.JOURNAL OF CONTROLLED RELEASE. VOL. 172. ISSUE 3. P. 1075-1091 | 54 | 40% | 76 |
4 | SAHOO, N , SAHOO, RK , BISWAS, N , GUHA, A , KUOTSU, K , (2015) RECENT ADVANCEMENT OF GELATIN NANOPARTICLES IN DRUG AND VACCINE DELIVERY.INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. VOL. 81. ISSUE . P. 317 -331 | 48 | 32% | 6 |
5 | CECCO, S , ALIBERTI, M , BALDO, P , GIACOMIN, E , LEONE, R , (2014) SAFETY AND EFFICACY EVALUATION OF ALBUMIN-BOUND PACLITAXEL.EXPERT OPINION ON DRUG SAFETY. VOL. 13. ISSUE 4. P. 511 -520 | 23 | 64% | 7 |
6 | VIUDEZ, A , RAMIREZ, N , HERNANDEZ-GARCIA, I , CARVALHO, FL , VERA, R , HIDALGO, M , (2014) NAB-PACLITAXEL: A FLATTERING FACELIFT.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 92. ISSUE 3. P. 166 -180 | 34 | 41% | 10 |
7 | BLAIR, HA , DEEKS, ED , (2015) ALBUMIN-BOUND PACLITAXEL: A REVIEW IN NON-SMALL CELL LUNG CANCER.DRUGS. VOL. 75. ISSUE 17. P. 2017 -2024 | 22 | 65% | 3 |
8 | JAHANBAN-ESFAHLAN, A , DASTMALCHI, S , DAVARAN, S , (2016) A SIMPLE IMPROVED DESOLVATION METHOD FOR THE RAPID PREPARATION OF ALBUMIN NANOPARTICLES.INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. VOL. 91. ISSUE . P. 703 -709 | 17 | 77% | 1 |
9 | MARME, F , CORTES, J , RICEVUTO, E , LEONARD, R , LLOMBART-CUSSAC, A , ARPINO, G , (2016) TAILORING THE DOSING SCHEDULE OF NAB-PACLITAXEL IN METASTATIC BREAST CANCER ACCORDING TO PATIENT AND DISEASE CHARACTERISTICS: RECOMMENDATIONS FROM A PANEL OF EXPERTS.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 99. ISSUE . P. 81 -90 | 22 | 55% | 2 |
10 | KARIMI, M , BAHRAMI, S , RAVARI, SB , ZANGABAD, PS , MIRSHEKARI, H , BOZORGOMID, M , SHAHREZA, S , SORI, M , HAMBLIN, MR , (2016) ALBUMIN NANOSTRUCTURES AS ADVANCED DRUG DELIVERY SYSTEMS.EXPERT OPINION ON DRUG DELIVERY. VOL. 13. ISSUE 11. P. 1609 -1623 | 38 | 33% | 0 |
Classes with closest relation at Level 1 |